Clinical Trial Update: A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan [Phase 2, Phase 3]

View source ↗

Summary

Takeda completed Phase 2 and Phase 3 trials of the Dengue Tetravalent Vaccine (TDV) in healthy participants in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Dengue Tetravalent Vaccine (TDV) (Dengue tetravalent vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Phase 2, Phase 3 | Status: COMPLETED